Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation

Rosario Amato1, Lucia D'Antona, Giovanni Porciatti

  • 1Department of Experimental and clinical Medicine G. Salvatore, Faculty of Medicine, University Magna Graecia at Catanzaro, Catanzaro, Italy.

Journal of Molecular Medicine (Berlin, Germany)
|September 17, 2009
PubMed

Insights

Serum and glucocorticoid regulated kinase 1 (Sgk1) enhances p53 ubiquitylation, promoting cell survival and cancer chemotherapy resistance. This kinase activity, regulated by p53, suggests a feedback loop influencing tumor progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Serum and glucocorticoid regulated kinase 1 (Sgk1) is a key kinase involved in cell survival and steroid signaling.
  • Sgk1 activation is linked to growth factor signaling and may contribute to cancer chemotherapy resistance.
  • The interplay between Sgk1 and the tumor suppressor p53 is not fully understood.

Purpose of the Study:

  • To investigate the role of Sgk1 in p53 ubiquitylation and its downstream effects.
  • To elucidate the functional relationship between Sgk1 and p53 in cancer cells.
  • To propose a regulatory model for Sgk1 and p53 interaction.

Main Methods:

  • Sgk1-specific RNA silencing in RKO and other cell lines.
  • Experiments in a mouse model and transfected HeLa cells (wild-type and dominant-negative Sgk1).
  • Analysis of p53 ubiquitylation, cell survival, cell-cycle progression, and clonogenic potential.

Main Results:

  • Sgk1 was demonstrated to activate MDM2-dependent p53 ubiquitylation.
  • Sgk1 influences cell survival, cell-cycle progression, and epithelial de-differentiation.
  • The impact of Sgk1 on cancer cell clonogenic potential is dependent on wild-type p53 expression.
  • A feedback loop was proposed where Sgk1 down-regulates p53 via ubiquitylation.

Conclusions:

  • Sgk1 plays a critical role in regulating p53 stability and function through ubiquitylation.
  • Sgk1 contributes to cancer cell survival and proliferation, with effects modulated by p53 status.
  • The findings suggest a novel feedback mechanism involving Sgk1 and p53 with implications for cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...